Formula (Neostigmine Premiereprorx 1)
Chemical structure diagram of Neostigmine Methylsulfate shown with its molecular groups and bonds.*
Neostigmine Methylsulfate Injection
Product Images NDC 0641-6277
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 0641-6277). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
10 mg Vial (Neostigmine Premiereprorx 2)
Neostigmine Methylsulfate Injection, USP 10 mg per 10 mL (1 mg/mL) multiple dose vial label. The label indicates intravenous use with USP controlled room temperature storage and protection from light. Manufactured by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ.*
10 mg Shelfpack (Neostigmine Premiereprorx 3)
Neostigmine Methylsulfate Injection, USP 10 mg per 10 mL (1 mg/mL) is shown on a vial label. The label indicates it is for intravenous use and contains 10 vials of 10 mL multiple dose each. It is manufactured by Hikma Pharmaceuticals USA Inc. The product NDC is 0641-6277-10.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
